- $694.97m
- $642.97m
- $18.67m
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
OmniAb rises on drug discovery deal with Lilly worth up to $370 million
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
OmniAb rises on drug discovery deal with Lilly worth up to $370 mln
OmniAb Inc reports results for the quarter ended June 30 - Earnings Summary
OmniAb Q2 revenue beats analyst estimates, outlook raised
Brief: OmniAb Q2 EPS USD -0.05
OmniAb Inc expected to post a loss of 12 cents a share - Earnings Preview
OmniAb Q1 revenue beats estimates; raises 2026 outlook on partner program momentum
Brief: OmniAb Q1 EPS USD -0.06
OmniAb Q4 revenue falls 22%, misses expectations
Brief: OmniAb Q4 EPS USD -0.11
Brief: OmniAb Enters In Technology License And Services Agreement For Antibody Discovery With A Newly-Formed Incubated Company Of Arrowmark Partners And Viking Global Investors
OmniAb's Q3 revenue falls 47%, net loss widens marginally
Brief: OmniAb Q3 EPS USD -0.14
Brief: Omniab Inc Files For Offering Of Up To 21.3 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
U.S. STOCKS ON THE MOVE-Artelo Biosciences, Coya, Vital Energy
U.S. STOCKS ON THE MOVE-Artelo Biosciences, Coya, Vital Energy
OmniAb drops after $30 mln equity financing